These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 4843162

  • 1. Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma.
    Zaharko DS, Dedrick RL, Peale AL, Drake JC, Lutz RJ.
    J Pharmacol Exp Ther; 1974 Jun; 189(3):585-92. PubMed ID: 4843162
    [No Abstract] [Full Text] [Related]

  • 2. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM, Donsbach RC.
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract] [Full Text] [Related]

  • 3. Relative biochemical aspects of low and high doses of methotrexate in mice.
    Zaharko DS, Fung WP, Yang KH.
    Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175
    [Abstract] [Full Text] [Related]

  • 4. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
    Shapiro WR.
    Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
    [No Abstract] [Full Text] [Related]

  • 5. [Study of DNA synthesis in short-term cultures of mammalian cells in the evaluation of the reaction of tumor and normal tissues to irradiation and hyperthermia].
    Synzynys BI, Kolesnikova AI, Konopliannikova AG.
    Radiobiologiia; 1985 Oct; 25(2):179-84. PubMed ID: 4001315
    [Abstract] [Full Text] [Related]

  • 6. Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
    Wheeler GP, Alexander JA.
    Cancer Res; 1974 Aug; 34(8):1957-64. PubMed ID: 4842249
    [No Abstract] [Full Text] [Related]

  • 7. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
    Sirotnak FM, Donsbach RC, Dorick DM, Moccio DM.
    Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
    [No Abstract] [Full Text] [Related]

  • 8. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA, Young RC.
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [Abstract] [Full Text] [Related]

  • 9. The effect of inhibition of cytidine deaminase by tetrahydrouridine on the utilization of deoxycytidine and 5-bromodeoxycytidine for deoxyribonucleic acid synthesis.
    Cooper GM, Greer S.
    Mol Pharmacol; 1973 Nov; 9(6):698-703. PubMed ID: 4762631
    [No Abstract] [Full Text] [Related]

  • 10. The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells.
    Goldman ID, Fyfe MJ.
    Mol Pharmacol; 1974 Mar; 10(2):275-82. PubMed ID: 4859543
    [No Abstract] [Full Text] [Related]

  • 11. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
    Mayo JG.
    Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
    [No Abstract] [Full Text] [Related]

  • 12. L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y.
    Capizzi RL, Summers WP, Bertino JR.
    Ann N Y Acad Sci; 1971 Nov 30; 186():302-11. PubMed ID: 5289422
    [No Abstract] [Full Text] [Related]

  • 13. Preferential inhibition of DNA synthesis in mouse hemopoietic cells by halothane.
    Evenwel RF, Keizer HJ, van Putten LM.
    Cancer Res; 1976 Sep 30; 36(9 pt.1):3156-9. PubMed ID: 975081
    [Abstract] [Full Text] [Related]

  • 14. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
    Klubes P, Connelly K, Cerna I, Mandel HG.
    Cancer Res; 1978 Aug 30; 38(8):2325-31. PubMed ID: 667828
    [No Abstract] [Full Text] [Related]

  • 15. Growth rate and cell kill.
    Hryniuk WM, Bertino JR.
    Ann N Y Acad Sci; 1971 Nov 30; 186():330-42. PubMed ID: 5289425
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA, Chello PL, Bertino JR.
    Cancer Res; 1972 Oct 30; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
    Kawai M, Hillcoat BL.
    Cancer Res; 1974 Jul 30; 34(7):1619-26. PubMed ID: 4833915
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic basis for differences in methotrexate sensitivity of normal proliferative tissues in the mouse.
    Sirotnak FM, Moccio DM.
    Cancer Res; 1980 Apr 30; 40(4):1230-4. PubMed ID: 7357552
    [Abstract] [Full Text] [Related]

  • 19. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
    Chu BC, Whiteley JM.
    J Natl Cancer Inst; 1979 Jan 30; 62(1):79-82. PubMed ID: 281578
    [Abstract] [Full Text] [Related]

  • 20. Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma.
    Levin VA, Clancy TP, Ausman JI, Rall DP.
    J Natl Cancer Inst; 1972 Apr 30; 48(4):875-83. PubMed ID: 4537157
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.